An estrogen receptor basis for raloxifene action in boneProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998.
- 1 April 1999
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 69 (1-6) , 37-44
- https://doi.org/10.1016/s0960-0760(98)00147-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Molecular basis of agonism and antagonism in the oestrogen receptorNature, 1997
- Identification of an Estrogen Response Element Activated by Metabolites of 17β-Estradiol and RaloxifeneScience, 1996
- Selective estrogen receptor modulators: pharmacological profile in the rat uterus.Journal of the Society for Gynecologic Investigation, 1996
- Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogensMolecular Endocrinology, 1995
- Raloxifene preserves bone strength and bone mass in ovariectomized ratsEndocrinology, 1994
- Dual-energy X-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized ratsJournal of Bone and Mineral Research, 1994
- The effects of raloxifene on tibia histomorphometry in ovariectomized ratsEndocrinology, 1994
- Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.Journal of Clinical Investigation, 1994
- The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimerCell, 1988